TEACHERS ADVISORS, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$2,352,000
-40.3%
200,353
-32.0%
0.00%
-50.0%
Q4 2018$3,938,000
-52.4%
294,763
-50.0%
0.01%
+20.0%
Q3 2018$8,266,000
+80.8%
589,526
+102.7%
0.01%
-16.7%
Q2 2018$4,572,000
-16.3%
290,846
-12.4%
0.01%
-14.3%
Q1 2018$5,461,000
-68.3%
331,950
-65.2%
0.01%
-68.2%
Q4 2017$17,204,000
+2.4%
952,585
+9.4%
0.02%
-4.3%
Q3 2017$16,808,000
+74.3%
870,888
+6.6%
0.02%
+64.3%
Q2 2017$9,643,000
+348.9%
817,245
+316.9%
0.01%
+366.7%
Q1 2017$2,148,000
+60.4%
196,026
+6.3%
0.00%
+50.0%
Q4 2016$1,339,000
+62.9%
184,460
+45.8%
0.00%
+100.0%
Q3 2016$822,000
+27.4%
126,475
+7.1%
0.00%0.0%
Q2 2016$645,000
+53.2%
118,135
+31.2%
0.00%0.0%
Q1 2016$421,000
-6.0%
90,0230.0%0.00%0.0%
Q4 2015$448,000
+32.5%
90,0230.0%0.00%0.0%
Q3 2015$338,000
-37.5%
90,0230.0%0.00%0.0%
Q2 2015$541,000
+27.3%
90,023
+18.6%
0.00%0.0%
Q1 2015$425,000
+86.4%
75,9340.0%0.00%
Q4 2014$228,000
+11.8%
75,9340.0%0.00%
Q3 2014$204,000
-4.2%
75,9340.0%0.00%
Q2 2014$213,000
-49.9%
75,934
-22.0%
0.00%
-100.0%
Q1 2014$425,000
+120.2%
97,408
+62.4%
0.00%
Q4 2013$193,000
+103.2%
59,9980.0%0.00%
Q3 2013$95,000
-9.5%
59,998
-0.7%
0.00%
Q2 2013$105,00060,4440.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders